{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T00:16:07Z","timestamp":1767485767318,"version":"3.48.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Long-Term Efficacy and Safety Assessment of Growth Hormone Therapy in Chinese Children: An Open-Label, Multicenter, Prospective and Retrospective Observational Study","award":["2025-0502-01"],"award-info":[{"award-number":["2025-0502-01"]}]},{"name":"Clinical Value of Combined Exhaled Nitric Oxide and Pulmonary Function Testing for Early Identification of Acute Asthma Exacerbation Severity in Children","award":["2025-QSYN-005"],"award-info":[{"award-number":["2025-QSYN-005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-025-06681-8","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T02:02:40Z","timestamp":1763431360000},"page":"6285-6296","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum miR-493-3p as a diagnostic biomarker and epigenetic regulator targeting DPY30 in pediatric acute lymphoblastic leukemia"],"prefix":"10.1007","volume":"104","author":[{"given":"Hong","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaojian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"issue":"11","key":"6681_CR1","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.3324\/haematol.2020.247031","volume":"105","author":"H Inaba","year":"2020","unstructured":"Inaba H, Mullighan CG (2020) Pediatric acute lymphoblastic leukemia. Haematologica 105(11):2524\u20132539. https:\/\/doi.org\/10.3324\/haematol.2020.247031","journal-title":"Haematologica"},{"issue":"1","key":"6681_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/17474086.2020.1685866","volume":"13","author":"M Bloom","year":"2020","unstructured":"Bloom M, Maciaszek JL, Clark ME, Pui CH, Nichols KE (2020) Recent advances in genetic predisposition to pediatric acute lymphoblastic leukemia. Expert Rev Hematol 13(1):55\u201370. https:\/\/doi.org\/10.1080\/17474086.2020.1685866","journal-title":"Expert Rev Hematol"},{"key":"6681_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052755","author":"M Lejman","year":"2022","unstructured":"Lejman M, Cha\u0142upnik A, Chilimoniuk Z, Dobosz M (2022) Genetic biomarkers and their clinical implications in B-cell acute lymphoblastic leukemia in children. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23052755","journal-title":"Int J Mol Sci"},{"issue":"8","key":"6681_CR4","doi-asserted-by":"publisher","first-page":"835","DOI":"10.7499\/j.issn.1008-8830.2105004","volume":"23","author":"HQ Gao","year":"2021","unstructured":"Gao HQ, Guan XM, Wen XH, Shen YL, Guo YX, Dou Y et al (2021) Clinical features and prognosis of children with acute leukemias of ambiguous lineage under different diagnostic criteria. Zhongguo Dang Dai Er Ke Za zhi\u2009=\u2009Chinese. J Contemp Pediatr 23(8):835\u2013840. https:\/\/doi.org\/10.7499\/j.issn.1008-8830.2105004","journal-title":"J Contemp Pediatr"},{"issue":"19","key":"6681_CR5","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1200\/jco.21.02678","volume":"40","author":"DT Teachey","year":"2022","unstructured":"Teachey DT, Devidas M, Wood BL, Chen Z, Hayashi RJ, Hermiston ML et al (2022) Children\u2019s oncology group trial AALL1231: a phase III clinical trial testing bortezomib in newly diagnosed T-cell acute lymphoblastic leukemia and lymphoma. J Clin Oncol 40(19):2106\u20132118. https:\/\/doi.org\/10.1200\/jco.21.02678","journal-title":"J Clin Oncol"},{"issue":"14","key":"6681_CR6","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1080\/14656566.2021.1931683","volume":"22","author":"M Tardif","year":"2021","unstructured":"Tardif M, Souza A, Krajinovic M, Bittencourt H, Tran TH (2021) Molecular-based and antibody-based targeted pharmacological approaches in childhood acute lymphoblastic leukemia. Expert Opin Pharmacother 22(14):1871\u20131887. https:\/\/doi.org\/10.1080\/14656566.2021.1931683","journal-title":"Expert Opin Pharmacother"},{"issue":"8","key":"6681_CR7","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s12094-017-1638-x","volume":"19","author":"S Hajizamani","year":"2017","unstructured":"Hajizamani S, Shahjahani M, Shahrabi S, Saki N (2017) MicroRNAs as prognostic biomarker and relapse indicator in leukemia. Clinical & translational oncology: official publication of the federation of. Span Oncol Soc Natl Cancer Inst Mexico 19(8):951\u2013960. https:\/\/doi.org\/10.1007\/s12094-017-1638-x","journal-title":"Span Oncol Soc Natl Cancer Inst Mexico"},{"key":"6681_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065436","author":"DK Mendiola-Soto","year":"2023","unstructured":"Mendiola-Soto DK, B\u00e1rcenas-L\u00f3pez DA, P\u00e9rez-Amado CJ, Cruz-Miranda GM, Mej\u00eda-Arangur\u00e9 JM, Ram\u00edrez-Bello J et al (2023) Mirnas in hematopoiesis and acute lymphoblastic leukemia. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24065436","journal-title":"Int J Mol Sci"},{"key":"6681_CR9","doi-asserted-by":"publisher","unstructured":"Ramzi M, Shokrgozar N (2022) MicroRNAs: Regulatory Biomarkers in Acute Myeloid Leukemia and Graft Versus Host Disease. Clin Lab 68(2). https:\/\/doi.org\/10.7754\/Clin.Lab.2021.210621","DOI":"10.7754\/Clin.Lab.2021.210621"},{"issue":"11","key":"6681_CR10","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1080\/17474086.2021.2007763","volume":"14","author":"W Deng","year":"2021","unstructured":"Deng W, Pan M, Zhu S, Chao R, Wang L (2021) Emerging roles of micrornas in acute lymphoblastic leukemia and their clinical prospects. Expert Rev Hematol 14(11):987\u2013992. https:\/\/doi.org\/10.1080\/17474086.2021.2007763","journal-title":"Expert Rev Hematol"},{"issue":"3","key":"6681_CR11","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00018-018-2958-x","volume":"76","author":"M Kleemann","year":"2019","unstructured":"Kleemann M, Schneider H, Unger K, Bereuther J, Fischer S, Sander P et al (2019) Induction of apoptosis in ovarian cancer cells by miR-493-3p directly targeting AKT2, STK38L, HMGA2, ETS1 and E2F5. Cell Mol Life Sci 76(3):539\u2013559. https:\/\/doi.org\/10.1007\/s00018-018-2958-x","journal-title":"Cell Mol Life Sci"},{"issue":"11","key":"6681_CR12","doi-asserted-by":"publisher","first-page":"12267","DOI":"10.18632\/oncotarget.7860","volume":"7","author":"M Tambe","year":"2016","unstructured":"Tambe M, Pruikkonen S, M\u00e4ki-Jouppila J, Chen P, Elgaaen BV, Straume AH et al (2016) Novel Mad2-targeting miR-493-3p controls mitotic fidelity and cancer cells\u2019 sensitivity to paclitaxel. Oncotarget 7(11):12267\u201312285. https:\/\/doi.org\/10.18632\/oncotarget.7860","journal-title":"Oncotarget"},{"issue":"18","key":"6681_CR13","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1080\/15384101.2023.2271341","volume":"22","author":"M Yao","year":"2023","unstructured":"Yao M, Mao X, Zhang Z, Xi Y, Gan H, Cui F et al (2023) Tumor-derived circRNA_102191 promotes gastric cancer and facilitates M2 macrophage polarization. Cell Cycle 22(18):2003\u20132017. https:\/\/doi.org\/10.1080\/15384101.2023.2271341","journal-title":"Cell Cycle"},{"issue":"1","key":"6681_CR14","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s11033-019-04600-5","volume":"46","author":"E Valiollahi","year":"2019","unstructured":"Valiollahi E, Ribera JM, Genesc\u00e0 E, Behravan J (2019) Genome-wide identification of microrna signatures associated with stem\/progenitor cells in Philadelphia chromosome-positive acute lymphoblastic leukemia. Mol Biol Rep 46(1):1295\u20131306. https:\/\/doi.org\/10.1007\/s11033-019-04600-5","journal-title":"Mol Biol Rep"},{"issue":"2","key":"6681_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.6004\/jnccn.2025.0006","volume":"23","author":"H Inaba","year":"2025","unstructured":"Inaba H, Teachey D, Annesley C, Batra S, Beck J, Colace S et al (2025) Pediatric acute lymphoblastic leukemia, version 2.2025, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 23(2):41\u201362. https:\/\/doi.org\/10.6004\/jnccn.2025.0006","journal-title":"J Natl Compr Canc Netw"},{"issue":"6","key":"6681_CR16","doi-asserted-by":"publisher","first-page":"573","DOI":"10.12047\/j.cjap.5856.2019.126","volume":"35","author":"KF Ma","year":"2019","unstructured":"Ma KF, Yang SG, Liu SJ (2019) [Construction of eukaryotic expression plasmid of pcDNA3.1(+)- CTGF and its expression in human osteoblast-like cells SaOS-2]. Zhongguo Ying Yong Sheng Li Xue Za zhi\u2009=\u2009Zhongguo Yingyong Shenglixue Zazhi\u2009=\u2009Chinese. J Appl Physiol 35(6):573\u2013576. https:\/\/doi.org\/10.12047\/j.cjap.5856.2019.126","journal-title":"J Appl Physiol"},{"issue":"7","key":"6681_CR17","doi-asserted-by":"publisher","first-page":"19250","DOI":"10.1007\/s11356-022-23537-0","volume":"30","author":"Q Yao","year":"2023","unstructured":"Yao Q, Zhang L, Liu Z, Yu L, Wang Y, Liu J et al (2023) LncRNA MAFG-AS1-induced acute myeloid leukemia development via modulating miR-147b\/HOXA9. Environ Sci Pollut Res Int 30(7):19250\u201319258. https:\/\/doi.org\/10.1007\/s11356-022-23537-0","journal-title":"Environ Sci Pollut Res Int"},{"issue":"1","key":"6681_CR18","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2024.2315651","volume":"25","author":"M Xia","year":"2024","unstructured":"Xia M, Chen J, Hu Y, Qu B, Bu Q, Shen H (2024) MiR-10b-5p promotes tumor growth by regulating cell metabolism in liver cancer via targeting SLC38A2. Cancer Biol Ther 25(1):2315651. https:\/\/doi.org\/10.1080\/15384047.2024.2315651","journal-title":"Cancer Biol Ther"},{"key":"6681_CR19","doi-asserted-by":"crossref","unstructured":"Meng M, Guan G, Liu X, Sun W, Cui X, Fu S et al (2024) miR-7160 inhibits gastric cancer cell proliferation and metastasis by Silencing SIX1. J Genet. 103","DOI":"10.1007\/s12041-024-01479-5"},{"issue":"1","key":"6681_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/mop.0000000000000855","volume":"32","author":"CW Elgarten","year":"2020","unstructured":"Elgarten CW, Aplenc R (2020) Pediatric acute myeloid leukemia: updates on biology, risk stratification, and therapy. Curr Opin Pediatr 32(1):57\u201366. https:\/\/doi.org\/10.1097\/mop.0000000000000855","journal-title":"Curr Opin Pediatr"},{"key":"6681_CR21","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.semcancer.2020.10.013","volume":"84","author":"TH Tran","year":"2022","unstructured":"Tran TH, Hunger SP (2022) The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities. Semin Cancer Biol 84:144\u2013152. https:\/\/doi.org\/10.1016\/j.semcancer.2020.10.013","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"6681_CR22","doi-asserted-by":"publisher","first-page":"365","DOI":"10.5114\/ceji.2021.109794","volume":"46","author":"M Pierzyna-\u015awita\u0142a","year":"2021","unstructured":"Pierzyna-\u015awita\u0142a M, S\u0119dek \u0141, Kulis J, Mazur B, Muszy\u0144ska-Ros\u0142an K, Ko\u0142tan A et al (2021) Multicolor flow cytometry immunophenotyping and characterization of aneuploidy in pediatric B-cell precursor acute lymphoblastic leukemia. Cent Eur J Immunol 46(3):365\u2013374. https:\/\/doi.org\/10.5114\/ceji.2021.109794","journal-title":"Cent Eur J Immunol"},{"issue":"22","key":"6681_CR23","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.1002\/cncr.35481","volume":"130","author":"X Zhang","year":"2024","unstructured":"Zhang X, Wang Y, Tian X, Sun L, Jiang H, Chu J et al (2024) Delineation of features, responses, outcomes, and prognostic factors in pediatric PDGFRB-positive acute lymphoblastic leukemia patients: a retrospective multicenter study. Cancer 130(22):3902\u20133912. https:\/\/doi.org\/10.1002\/cncr.35481","journal-title":"Cancer"},{"issue":"10","key":"6681_CR24","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.3324\/haematol.2018.214593","volume":"104","author":"A Gao","year":"2019","unstructured":"Gao A, Gong Y, Zhu C, Yang W, Li Q, Zhao M et al (2019) Bone marrow endothelial cell-derived interleukin-4 contributes to thrombocytopenia in acute myeloid leukemia. Haematologica 104(10):1950\u20131961. https:\/\/doi.org\/10.3324\/haematol.2018.214593","journal-title":"Haematologica"},{"issue":"2","key":"6681_CR25","first-page":"291","volume":"7","author":"V Buga Corbu","year":"2014","unstructured":"Buga Corbu V, Gl\u0171ck A, Arion C (2014) Actual biological diagnosis of acute myeloblastic leukemia in children. J Med Life 7(2):291\u2013295","journal-title":"J Med Life"},{"issue":"12","key":"6681_CR26","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1007\/s11912-024-01608-4","volume":"26","author":"S Elgazar","year":"2024","unstructured":"Elgazar S, Constantinou C (2024) Paediatric acute lymphoblastic leukaemia: a narrative review of current knowledge and advancements. Curr Oncol Rep 26(12):1586\u20131599. https:\/\/doi.org\/10.1007\/s11912-024-01608-4","journal-title":"Curr Oncol Rep"},{"issue":"23","key":"6681_CR27","doi-asserted-by":"publisher","first-page":"10379","DOI":"10.26355\/eurrev_201912_19677","volume":"23","author":"XY Wang","year":"2019","unstructured":"Wang XY, Wang L, Xu PC, Huang FJ, Jian X, Wei ZC et al (2019) LINC01605 promotes the proliferation of laryngeal squamous cell carcinoma through targeting miR-493-3p. Eur Rev Med Pharmacol Sci 23(23):10379\u201310386. https:\/\/doi.org\/10.26355\/eurrev_201912_19677","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"6681_CR28","doi-asserted-by":"publisher","first-page":"7698706","DOI":"10.1155\/2023\/7698706","volume":"2023","author":"K Zhan","year":"2023","unstructured":"Zhan K, Song X, Zhang Q, Yang J, Lu S, Propofol-Induced (2023) miR-493-3p inhibits growth and invasion of gastric cancer through suppression of DKK1-Mediated Wnt\/\u03b2-Catenin signaling activation. Dis Markers 2023:7698706. https:\/\/doi.org\/10.1155\/2023\/7698706","journal-title":"Dis Markers"},{"issue":"11","key":"6681_CR29","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1182\/blood-2016-10-697698","volume":"130","author":"JA Wallace","year":"2017","unstructured":"Wallace JA, O\u2019Connell RM (2017) Micrornas and acute myeloid leukemia: therapeutic implications and emerging concepts. Blood 130(11):1290\u20131301. https:\/\/doi.org\/10.1182\/blood-2016-10-697698","journal-title":"Blood"},{"issue":"2","key":"6681_CR30","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1080\/10428194.2018.1480769","volume":"60","author":"C He","year":"2019","unstructured":"He C, Luo B, Jiang N, Liang Y, He Y, Zeng J et al (2019) Oncomir or antioncomir: role of miRNAs in acute myeloid leukemia. Leuk Lymphoma 60(2):284\u2013294. https:\/\/doi.org\/10.1080\/10428194.2018.1480769","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"6681_CR31","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.18632\/oncotarget.12343","volume":"8","author":"Q Liao","year":"2017","unstructured":"Liao Q, Wang B, Li X, Jiang G (2017) Mirnas in acute myeloid leukemia. Oncotarget 8(2):3666\u20133682. https:\/\/doi.org\/10.18632\/oncotarget.12343","journal-title":"Oncotarget"},{"issue":"2","key":"6681_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.repbio.2022.100610","volume":"22","author":"Q Liu","year":"2022","unstructured":"Liu Q, Yang H, Hua H (2022) Overexpression of miR-493-3p suppresses ovarian cancer cell proliferation, migration and invasion through downregulating DPY30. Reprod Biol 22(2):100610. https:\/\/doi.org\/10.1016\/j.repbio.2022.100610","journal-title":"Reprod Biol"},{"issue":"13","key":"6681_CR33","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1182\/blood-2014-01-549220","volume":"124","author":"Z Yang","year":"2014","unstructured":"Yang Z, Augustin J, Chang C, Hu J, Shah K, Chang CW et al (2014) The DPY30 subunit in SET1\/MLL complexes regulates the proliferation and differentiation of hematopoietic progenitor cells. Blood 124(13):2025\u20132033. https:\/\/doi.org\/10.1182\/blood-2014-01-549220","journal-title":"Blood"},{"key":"6681_CR34","doi-asserted-by":"publisher","first-page":"5595","DOI":"10.2147\/jir.S377678","volume":"15","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Han Y, Sun Q, Wang Y, Sun L (2022) The DPY30-H3K4me3 Axis-Mediated PD-L1 expression in melanoma. J Inflamm Res 15:5595\u20135609. https:\/\/doi.org\/10.2147\/jir.S377678","journal-title":"J Inflamm Res"},{"issue":"1","key":"6681_CR35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13045-020-00935-w","volume":"13","author":"Y Jia","year":"2020","unstructured":"Jia Y, Liu W, Zhan HE, Yi XP, Liang H, Zheng QL et al (2020) Roles of hsa-miR-12462 and SLC9A1 in acute myeloid leukemia. J Hematol Oncol 13(1):101. https:\/\/doi.org\/10.1186\/s13045-020-00935-w","journal-title":"J Hematol Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06681-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06681-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06681-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T00:15:16Z","timestamp":1767485716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06681-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":35,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6681"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06681-8","relation":{},"ISSN":["1432-0584"],"issn-type":[{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"30 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Zhoushan Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from the parents.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}